Ao Yu

455 total citations
16 papers, 368 citations indexed

About

Ao Yu is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Ao Yu has authored 16 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Surgery. Recurrent topics in Ao Yu's work include RNA Interference and Gene Delivery (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). Ao Yu is often cited by papers focused on RNA Interference and Gene Delivery (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). Ao Yu collaborates with scholars based in United States, China and Czechia. Ao Yu's co-authors include David Oupický, Weimin Tang, Hang Yu, Ling Ding, Ying Xie, Jing Li, Rakesh K. Singh, Richard Sleightholm, Yazhe Wang and Dipakkumar R. Prajapati and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and Biomaterials.

In The Last Decade

Ao Yu

16 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ao Yu United States	9	186	95	94	81	58	16	368
Hang Yu United States	11	223 1.2×	111 1.2×	124 1.3×	113 1.4×	72 1.2×	26	432
Xianying Meng China	15	261 1.4×	27 0.3×	113 1.2×	111 1.4×	149 2.6×	38	529
Simona Ruxandra Volovăț Romania	11	157 0.8×	41 0.4×	37 0.4×	106 1.3×	95 1.6×	41	372
Chenbei Li China	8	112 0.6×	25 0.3×	48 0.5×	37 0.5×	47 0.8×	23	265
Dikran Sarko Germany	6	215 1.2×	66 0.7×	38 0.4×	52 0.6×	14 0.2×	6	346
Shao‐Chen Yang China	10	334 1.8×	122 1.3×	321 3.4×	146 1.8×	70 1.2×	13	641
Michèle Harrison Ireland	8	211 1.1×	28 0.3×	38 0.4×	162 2.0×	125 2.2×	9	444
Hailing Tang China	12	216 1.2×	70 0.7×	44 0.5×	109 1.3×	89 1.5×	24	402
Yu Pang China	8	121 0.7×	16 0.2×	81 0.9×	48 0.6×	54 0.9×	24	359

Countries citing papers authored by Ao Yu

Since Specialization

Citations

This map shows the geographic impact of Ao Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ao Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ao Yu more than expected).

Fields of papers citing papers by Ao Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ao Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ao Yu. The network helps show where Ao Yu may publish in the future.

Co-authorship network of co-authors of Ao Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Ao Yu. A scholar is included among the top collaborators of Ao Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ao Yu. Ao Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Yu, Ao, et al.. (2024). Immune Checkpoint Inhibitor Combined with Antiangiogenic Agent Synergistically Improving the Treatment Efficacy for Solid Tumors. ImmunoTargets and Therapy. Volume 13. 813–829. 7 indexed citations

Dong, Weiwei, You Li, Juan Zeng, et al.. (2024). SIRT1: a novel regulator in colorectal cancer. Biomedicine & Pharmacotherapy. 178. 117176–117176. 4 indexed citations

Yu, Ao, Wei Zhang, Qiang‐Sheng Zhang, et al.. (2024). A TICT-AIE activated dual-channel fluorescence-on probe to reveal the dynamics mechanosensing of lipid droplets during ferroptosis. Talanta. 274. 126028–126028. 11 indexed citations

Jia, Huizhen, Ling Ding, Ao Yu, et al.. (2022). A boronate-based modular assembly nanosystem to block the undesirable crosstalk between hepatic stellate cells and Kupffer cells. Bioactive Materials. 25. 569–579. 8 indexed citations

Sil, Diptesh, Sudipta Panja, Raj Kumar, et al.. (2022). Self-Assembled Alkylated Polyamine Analogs as Supramolecular Anticancer Agents. Molecules. 27(8). 2441–2441. 2 indexed citations

Ding, Ling, Siyuan Tang, Ao Yu, et al.. (2022). Nanoemulsion-Assisted siRNA Delivery to Modulate the Nervous Tumor Microenvironment in the Treatment of Pancreatic Cancer. ACS Applied Materials & Interfaces. 14(8). 10015–10029. 12 indexed citations

Holbert, Cassandra E., Jackson R. Foley, Ao Yu, et al.. (2022). Polyamine-Based Nanostructures Share Polyamine Transport Mechanisms with Native Polyamines and Their Analogues: Significance for Polyamine-Targeted Therapy. SHILAP Revista de lepidopterología. 10(3). 44–44. 8 indexed citations

Ding, Ling, Siyuan Tang, Weimin Tang, et al.. (2022). Perfluorocarbon Nanoemulsions Enhance Therapeutic siRNA Delivery in the Treatment of Pulmonary Fibrosis. Advanced Science. 9(8). e2103676–e2103676. 25 indexed citations

Tang, Weimin, et al.. (2022). Study of Renal Accumulation of Targeted Polycations in Acute Kidney Injury. Biomacromolecules. 23(5). 2064–2074. 4 indexed citations

10.

Tang, Weimin, Sudipta Panja, Siyuan Tang, et al.. (2022). Modified chitosan for effective renal delivery of siRNA to treat acute kidney injury. Biomaterials. 285. 121562–121562. 54 indexed citations

11.

Yu, Ao, Siyuan Tang, Ling Ding, et al.. (2022). Hyaluronate-coated perfluoroalkyl polyamine prodrugs as bioactive siRNA delivery systems for the treatment of peritoneal cancers. Biomaterials Advances. 136. 212755–212755. 11 indexed citations

12.

Tang, Siyuan, Ling Ding, Ao Yu, et al.. (2022). Effect of tocopherol conjugation on polycation-mediated siRNA delivery to orthotopic pancreatic tumors. Biomaterials Advances. 145. 213236–213236. 5 indexed citations

13.

Tang, Siyuan, Hang Yu, Ling Ding, et al.. (2021). Intraperitoneal siRNA Nanoparticles for Augmentation of Gemcitabine Efficacy in the Treatment of Pancreatic Cancer. Molecular Pharmaceutics. 18(12). 4448–4458. 27 indexed citations

14.

Yu, Hang, Siyuan Tang, Weimin Tang, et al.. (2021). Polycation fluorination improves intraperitoneal siRNA delivery in metastatic pancreatic cancer. Journal of Controlled Release. 333. 139–150. 26 indexed citations

15.

Tang, Weimin, Yi Chen, Hee‐Seong Jang, et al.. (2021). Preferential siRNA delivery to injured kidneys for combination treatment of acute kidney injury. Journal of Controlled Release. 341. 300–313. 32 indexed citations

16.

Xie, Ying, Hang Yu, Yazhe Wang, et al.. (2020). Stromal Modulation and Treatment of Metastatic Pancreatic Cancer with Local Intraperitoneal Triple miRNA/siRNA Nanotherapy. ACS Nano. 14(1). 255–271. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact